These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Drug information resources for health professionals and consumers. Durkin C Natl Netw; 1998 Feb; 22(3):10-1. PubMed ID: 10176590 [No Abstract] [Full Text] [Related]
4. Remarks at the Food and Drug Law Institute's 48th Annual Conference. Niedelman SM Food Drug Law J; 2005; 60(2):117-26. PubMed ID: 16097089 [No Abstract] [Full Text] [Related]
5. [Quick drug investigations; desirable, useful and steady work]. Olofsson C Vardfacket; 1978 Aug; 2(15):42-5. PubMed ID: 250385 [No Abstract] [Full Text] [Related]
6. Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny. Strawn MN J Contemp Health Law Policy; 2003; 19(2):495-520. PubMed ID: 14748255 [No Abstract] [Full Text] [Related]
7. Inaccessibility of drug reports. Lexchin J CMAJ; 2002 May; 166(10):1251. PubMed ID: 12041834 [No Abstract] [Full Text] [Related]
8. Biopure moves to sell blood substitute in Europe. Burton TM Wall St J (East Ed); 2006 Jul; ():D2. PubMed ID: 16906689 [No Abstract] [Full Text] [Related]
9. [The Medical Product Agency's work and economics--a comment]. Ahlqvist Rastad J; Salmonson T Lakartidningen; 2003 Jan; 100(5):345. PubMed ID: 12607382 [No Abstract] [Full Text] [Related]
10. Why the drug development pipeline is not delivering better medicines. Naci H; Carter AW; Mossialos E BMJ; 2015 Oct; 351():h5542. PubMed ID: 26496934 [No Abstract] [Full Text] [Related]
11. [Strange reaction to drug therapy]. Aarbakke J; Rasmussen K Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1910. PubMed ID: 12830285 [No Abstract] [Full Text] [Related]
12. Special section on analysis and evaluation of the drug industry. Introduction to the theme: the role of the drug industry in modern health services systems. Stolley PD Int J Health Serv; 1974; 4(1):59-60. PubMed ID: 4829899 [No Abstract] [Full Text] [Related]
14. ["The safety of drugs a stepchild of medicine". Calcium blockers not the only example]. Karlsson Y Lakartidningen; 1996 Oct; 93(43):3804-6. PubMed ID: 8965557 [No Abstract] [Full Text] [Related]
15. [Two years with EMEA: towards a unified drug registration within the EEC]. Lennholm B Lakartidningen; 1997 Jan; 94(1-2):8-12. PubMed ID: 9053613 [No Abstract] [Full Text] [Related]
16. The role of the pharmaceutical industry in disseminating pharmacovigilance practice in developing countries. Shani S; Yahalom Z Food Drug Law J; 2008; 63(3):701-11. PubMed ID: 19031669 [No Abstract] [Full Text] [Related]
17. Drug safety. Gaps in the safety net. Couzin J Science; 2005 Jan; 307(5707):196-8. PubMed ID: 15653480 [No Abstract] [Full Text] [Related]
18. The challenges of globalization in pharmaceutical law--is an international drug approval system modeled after the European system worth considering? Purnhagen KP Food Drug Law J; 2008; 63(3):623-45. PubMed ID: 19031663 [No Abstract] [Full Text] [Related]
19. Secrecy and the health protection branch. Lexchin J CMAJ; 1998 Sep; 159(5):481-3. PubMed ID: 9757171 [No Abstract] [Full Text] [Related]